Omega Fund V L.P. 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:48 pm Sale | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Omega Fund V L.P. | 62,500 1.800% | -100,262 (-61.60%) | Filing |
| 2021-02-12 1:51 pm Purchase | 2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Omega Fund V L.P. | 162,762 7.200% | 18,237 (+12.62%) | Filing |
| 2020-02-14 1:09 pm Purchase | 2019-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Omega Fund V L.P. | 144,526 8.400% | 69,086 (+91.58%) | Filing |